Condition
High-grade B-cell Lymphoma (HGBL) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 High-grade B-cell Lymphoma (HGBL) clinical trials that are recruiting, at sites in 2 countries (most in South Korea (1), Germany (1)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
TC011 (CD19 CAR-T) for relapsed or refractory large B‑cell lymphoma
This will test a CD19-targeted CAR-T therapy called TC011 in adults whose large B‑cell lymphoma has relapsed or not responded after prior treatments.
-
Combining loncastuximab tesirine and epcoritamab in relapsed/refractory aggressive B‑cell lymphoma
In this phase 2 study, researchers will test whether the drug combo loncastuximab tesirine plus epcoritamab can help people with relapsed or refractory aggressive B‑cell lymphomas, including DLBCL, HGBL, or FL 3B, who have failed prior therapies or CAR‑T treatment.
Related topics
Quick answers
How many High-grade B-cell Lymphoma (HGBL) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in South Korea (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.